Previous 10 | Next 10 |
Summary This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion in Assets Under Management. From 1/2/2016 to date investing in all 50 stocks, equally weighted, would have produced a total retu...
--News Direct-- We are honored to be named a Best Place to Work for Disability Inclusion for the 7th consecutive year by Disability:IN and American Association of People with Disabilities. We strive to create equal opportunities for everyone to participate fully and meaningfully. Ab...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Boston Scientific ( NYSE: BSX ) acquired privately-held Obsidio, a developer of Gel Embolic Material (GEM) technology used for embolization of blood vessels in the peripheral vasculature. Terms of the transaction were not disclosed. Embolization is a proc...
Boston Scientific Announces Acquisition of Obsidio, Inc. PR Newswire Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio MARLBOROUGH, Mass. , Aug. 15, 2022 /PRNewswire/ -- Bos...
In its recent 13-F filing , Larry Robbins and Mark Horowitz owned fund Glenview Capital indicated that it has acquired new stakes in Microsoft ( MSFT ) with 0.2M shares, Willis Towers Watson ( WTW ) with 0.13M shares, ZoomInfo Technologies ( ZI ) with 0.3M shares...
The Health Care Sector ETF has beaten the S&P 500 this year, but there has been a recent relative weakness. One medical device company impressed the Street in late July with a bottom line beat and could see near-term price upside. Longer-term, though, the highly-priced stock i...
--News Direct-- Diverse perspectives are essential to innovation. We’re proud to be recognized as one of Seramount, part of EAB's Best Companies for Multicultural Women for our commitment to recruiting, retaining and advancing multicultural women. About Boston Scientific ...
Analysis of the top ten pharma and medical device companies shows a 2% advantage for medical device on a total return basis over the last ten years. There are many possible reasons for this difference but patent cliffs and litigation are problems for Pharma. Investors seeking supe...
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. After the Q1-2022 13F filings the consensus holdings were updated, 10 stocks were removed and 8 added from the univ...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...